Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Update

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totaling 65,392 shares, a drop of 70.6% from the June 15th total of 222,527 shares. Approximately 7.1% of the company’s stock are sold short. Based on an average trading volume of 5,387,370 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Cuprina Holdings (Cayman) Trading Down 12.9%

Shares of NASDAQ:CUPR traded down $0.64 on Monday, hitting $4.33. 33,005 shares of the company were exchanged, compared to its average volume of 1,606,959. Cuprina Holdings has a 1-year low of $1.76 and a 1-year high of $76.00. The stock has a 50 day moving average price of $3.57. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last released its earnings results on Monday, April 27th. The company reported ($0.40) earnings per share (EPS) for the quarter. The company had revenue of $0.01 million during the quarter.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.